<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">Молодежный инновационный вестник</journal-id><journal-title-group><journal-title>Молодежный инновационный вестник</journal-title></journal-title-group><issn publication-format="print">2415-7805</issn><publisher><publisher-name>Федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный медицинский университет имени Н.Н. Бурденко" Министерства здравоохранения Российской Федерации</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">9395</article-id><article-categories><subj-group subj-group-type="heading"><subject>Conference Proceedings</subject></subj-group></article-categories><title-group><article-title>Market analysis of medicines for the fight against multiple sclerosis: marketing research</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Kovalenko</surname><given-names>Sofia Vladimirovna</given-names></name><bio>&lt;p&gt;Student&lt;/p&gt;</bio><email>skowa97@yandex.ru</email><uri content-type="orcid">https://orcid.org/0009-0005-6565-3701</uri><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Oleynikova</surname><given-names>Tatiana Anatolievna</given-names></name><bio>&lt;p&gt;Candidate of Pharmaceutical Sciences, Associate Professor of the Department of Organization and Management of Pharmacy&lt;/p&gt;</bio><email>ol_tanja@mail.ru</email><uri content-type="orcid">https://orcid.org/0000-0001-7354-8286</uri><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">Kursk State Medical University</aff><pub-date date-type="epub" iso-8601-date="2024-04-19" publication-format="electronic"><day>19</day><month>04</month><year>2024</year></pub-date><volume>13</volume><issue>S1</issue><fpage>585</fpage><lpage>588</lpage><history><pub-date date-type="received" iso-8601-date="2024-02-12"><day>12</day><month>02</month><year>2024</year></pub-date><pub-date date-type="accepted" iso-8601-date="2024-04-10"><day>10</day><month>04</month><year>2024</year></pub-date></history><permissions><copyright-statement>Copyright © 2024, Kovalenko S.V., Oleynikova T.A.</copyright-statement><copyright-year>2024</copyright-year></permissions><abstract>&lt;p&gt;&lt;em&gt;Introduction. The analysis of the nomenclature of medicines is one of the most demanded areas of marketing research of the pharmaceutical market, which is carried out not only to assess the rationality of the assortment, but also to develop recommendations for its development, which contributes to improving the quality of drug supply to the population. Multiple sclerosis is a rare disease with an unclear etiology that requires specific therapy. To date, multiple sclerosis is a socially significant disease. Modern therapy for multiple sclerosis mainly includes drug therapy. In this regard, it is of interest to consider the completeness and accessibility of the range of medicines to provide this category of patients. Goal. The study and analysis of a medicinal resource for the treatment of multiple sclerosis in the pharmaceutical market of Kursk and the country as a whole. Materials and methods. The materials of the study were clinical recommendations for the treatment of multiple sclerosis, the state register of medicines of Russia, the Vidal directory, the electronic reference service of pharmacies in Kursk. To achieve this goal, the following methods were used: meaningful analysis, generalization, systemic, structural, tabular, complex, logical types of analysis. Results. Based on the analysis of the nomenclature of medicines for the treatment of multiple sclerosis and a comparative analysis of the assortment of federal and regional market segments, the main directions of assortment policy in the pharmaceutical market of Kursk have been formed by expanding the range of dosage forms and trade names of medicinal products. Conclusion. Thanks to the conducted marketing research, results were obtained that will contribute to increasing the satisfaction of patients with these pathologies.&lt;/em&gt;&lt;/p&gt;&#13;
&lt;p&gt;&lt;/p&gt;</abstract><kwd-group xml:lang="en"><kwd>multiple sclerosis</kwd><kwd>assortment</kwd><kwd>medicines</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>рассеянный склероз</kwd><kwd>ассортимент</kwd><kwd>лекарственные препараты</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Рассеянный склероз. Клинические рекомендации РФ 2022 (Россия) [Электронный ресурс] // Режим доступа: URL: http://disuria.ru/_ld/12/1226_kr22G35p0MZ.pdf?ysclid=lq86h3v8de443100738 (Дата обращения: 26.12.2023).</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Пугачева, М. Г. Рассеянный склероз / М. Г. Пугачева, М. М. Щапкова // Academy. – 2021. – № 3(66). – С. 36-37. – EDN KCBJMH.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Государственный реестр ЛС. Официальный сайт [Электронный ресурс] // Режим доступа: URL: https://grls.minzdrav.gov.ru/grls.aspx (дата обращения 26.12.2023).</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Видаль. Официальный сайт [Электронный ресурс] // Режим доступа: URL: https://www.vidal.ru/drugs/nosology/g35 (Дата обращения: 16.12.2023).</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Справочная служба аптек. Официальный сайт [Электронный ресурс] // Режим доступа: URL: https://spravkaaptek.ru/?ysclid=lsakaoyk9q945491511 ( Дата обращения: 06.02. 2024).</mixed-citation></ref></ref-list></back></article>
